ZMAX Drug Patent Profile
✉ Email this page to a colleague
When do Zmax patents expire, and when can generic versions of Zmax launch?
Zmax is a drug marketed by Pf Prism Cv and is included in one NDA. There are two patents protecting this drug.
This drug has fifty-one patent family members in forty-three countries.
The generic ingredient in ZMAX is azithromycin. There are thirty-two drug master file entries for this compound. Sixty-two suppliers are listed for this compound. Additional details are available on the azithromycin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zmax
A generic version of ZMAX was approved as azithromycin by PLIVA on November 14th, 2005.
Summary for ZMAX
International Patents: | 51 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Patent Applications: | 3,137 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ZMAX |
What excipients (inactive ingredients) are in ZMAX? | ZMAX excipients list |
DailyMed Link: | ZMAX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for ZMAX
US Patents and Regulatory Information for ZMAX
ZMAX is protected by two US patents.
Patents protecting ZMAX
Azithromycin dosage forms with reduced side effects
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING BACTERIAL INFECTIONS
Multiparticulate crystalline drug compositions having controlled release profiles
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pf Prism Cv | ZMAX | azithromycin | FOR SUSPENSION, EXTENDED RELEASE;ORAL | 050797-001 | Jun 10, 2005 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Pf Prism Cv | ZMAX | azithromycin | FOR SUSPENSION, EXTENDED RELEASE;ORAL | 050797-001 | Jun 10, 2005 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZMAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pf Prism Cv | ZMAX | azithromycin | FOR SUSPENSION, EXTENDED RELEASE;ORAL | 050797-001 | Jun 10, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Pf Prism Cv | ZMAX | azithromycin | FOR SUSPENSION, EXTENDED RELEASE;ORAL | 050797-001 | Jun 10, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Pf Prism Cv | ZMAX | azithromycin | FOR SUSPENSION, EXTENDED RELEASE;ORAL | 050797-001 | Jun 10, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Pf Prism Cv | ZMAX | azithromycin | FOR SUSPENSION, EXTENDED RELEASE;ORAL | 050797-001 | Jun 10, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZMAX
See the table below for patents covering ZMAX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 1697648 | Azithromycin dosage forms with reduced side effects | ⤷ Try a Trial |
Slovakia | 143296 | CONTROLLED-RELEASE DOSAGE FORMS OF AZITHROMYCIN | ⤷ Try a Trial |
Georgia, Republic of | P20074056 | AZITHROMYCIN DOSAGE FORMS WITH REDUCED SIDE EFFECTS | ⤷ Try a Trial |
Austria | 407663 | ⤷ Try a Trial | |
Yugoslavia | 132588 | ⤷ Try a Trial | |
Russian Federation | 2130311 | MEDICINAL CONTROLLED-RELEASING FORMS OF AZITHROMYCIN | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |